The neurotrophic effects of PACAP in PC12 cells: Control by multiple transduction pathways

Journal of Neurochemistry

Volumn 98, Issue 2, 2006, Pages 321-329

  Ravni, Aurélia ^a   Bourgault, Steve ^a,b   Lebon, Alexis ^a   Chan, Philippe ^a   Galas, Ludovic ^a   Fournier, Alain ^b   Vaudry, Hubert ^a   Gonzalez, Bruno ^a   Eiden, Lee E ^c   Vaudry, David ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b INRS INSTITUT ARMAND FRAPPIER   (Canada)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Differentiation; Microarray; Nerve growth factor; PC12 cells; Pituitary adenylate cyclase activating polypeptide; Transduction pathways

Indexed keywords

HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; NEUROTROPHIN; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADRENAL GLAND; BIOSYNTHESIS; BRAIN; BRAIN CELL; CELL FUNCTION; CELL GROWTH; CELL STIMULATION; CELL STRUCTURE; CELL SURVIVAL; CEREBELLUM; HIPPOCAMPUS; LIGAND BINDING; NERVE CELL DIFFERENTIATION; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; NERVE GROWTH FACTORS; PC12 CELLS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

EID: 33746549738     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.03884.x     Document Type: Review

References (102)

1. Agapova L. S., Ilyinskaya G. V., Turovets N. A., Ivanov A. V., Chumakov P. M. and Kopnin B. P. (1996) Chromosome changes caused by alterations of p53 expression. Mutat. Res. 354, 129-138.
2. Aletta J. M., Lewis S. A., Cowan N. J. and Greene L. A. (1988) Nerve growth factor regulates both the phosphorylation and steady-state levels of microtubule-associated protein 1.2 (MAP1.2). J. Cell Biol. 106, 1573-1581.
3. Anderson S. T. and Curlewis J. D. (1998) PACAP stimulates dopamine neuronal activity in the medial basal hypothalamus and inhibits prolactin. Brain Res. 790, 343-346.
4. Angelastro J. M., Klimaschewski L., Tang S., Vitolo O. V., Weissman T. A., Donlin L. T., Shelanski M. L. and Greene L. A. (2000) Identification of diverse nerve growth factor-regulated genes by serial analysis of gene expression (SAGE) profiling. Proc. Natl Acad. Sci. USA 97, 10 424-10 429.
5. Aparicio L. F., Ocrant I., Boylan J. M. and Gruppuso P. A. (1992) Protein tyrosine phosphatase activation during nerve growth factor-induced neuronal differentiation of PC12 cells. Cell Growth Differ. 3, 363-367.
6. Ashcroft M., Stephens R. M., Hallberg B., Downward J. and Kaplan D. R. (1999) The selective and inducible activation of endogenous PI 3-kinase in PC12 cells results in efficient NGF-mediated survival but defective neunte outgrowth. Oncogene 18, 4586-4597.
7. Barrie A. P., Clohessy A. M., Buensuceso C. S., Rogers M. V. and Allen J. M. (1997) Pituitary adenylyl cyclase-activating peptide stimulates extracellular signal-regulated kinase 1 or 2 (ERK1/2) activity in a Ras-independent, mitogen-activated protein kinase/ERK kinase 1- or 2-dependent manner in PC12 cells. J. Biol. Chem. 272, 19 666-19 671.
8. Batistatou A. and Greene L. A. (1993) Internucleosomal DNA cleavage and neuronal cell survival/death. J. Cell Biol. 122, 523-532.
9. Beaudet M. M., Parsons R. L., Braas K. M. and May V. (2000) Mechanisms mediating pituitary adenylate cyclase-activating polypeptide depolarization of rat sympathetic neurons. J. Neurosci. 20, 7353-7361.
10. Bouschet T., Perez V., Fernandez C., Bockaert J., Eychene A. and Journot L. (2003) Stimulation of the ERK pathway by GTP-loaded Rap1 requires the concomitant activation of Ras, protein kinase C, and protein kinase A in neuronal cells. J. Biol. Chem. 278, 4778-4785.
11. Burgun C., Esteve L., Humblot N., Aunis D. and Zwiller J. (2000) Cyclic AMP-elevating agents induce the expression of MAP kinase phosphatase-1 in PC12 cells. FEBS Lett. 484, 189-193.
12. Chen Y., Hamelink C., Vaudry D., Xiang C., Brownstein M., Chen M., Chen Y., Hallenbeck J. and Eiden L. E. (2004) Expression profiling of cerebrocortical transcripts during middle cerebral artery occlusion and treatment with pituitary adenylate cyclase activating polypeptide (PACAP) in the mouse, in Pharmacology of Cerebral Ischemia (Krieglstein J. and Klumpp S., eds), pp. 267-277. Medpharm Scientific Publishers, Stuttgart.
13. Colbert R. A., Balbi D., Johnson A., Bailey J. A. and Allen J. M. (1994) Vasoactive intestinal peptide stimulates neuropeptide Y gene expression and causes neurite extension in PC12 cells through independent mechanisms. J. Neurosci. 14, 7141-7147.
14. Corbitt J., Vivekananda J., Wang S. S. and Strong R. (1998) Transcriptional and posttranscriptional control of tyrosine hydroxylase gene expression during persistent stimulation of pituitary adenylate cyclase-activating polypeptide receptors on PC12 cells: regulation by protein kinase A-dependent and protein kinase A-independent pathways. J. Neurochem. 71, 478-486.
15. Deak M., Clifton A. D., Lucocq L. M. and Alessi D. R. (1998) Mitogen-and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 17, 4426-4441.
16. Deutsch P. J. and Sun Y. (1992) The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. J. Biol. Chem. 267, 5108-5113.
17. Falluel-Morel A., Aubert N., Vaudry D., Basille M., Fontaine M., Fournier A., Vaudry H. and Gonzalez B. J. (2004) Opposite regulation of the mitochondrial apoptotic pathway by C2-ceramide and PACAP through a MAP-kinase-dependent mechanism in cerebellar granule cells. J. Neurochem. 91, 1231-1243.
18. Glebova N. O. and Ginty D. D. (2004) Heterogeneous requirement of NGF for sympathetic target innervation in vivo. J. Neurosci. 24, 743-751.
19. Greene L. A. and Tischler A. S. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl Acad. Sci. USA 73, 2424-2428.
20. Grewal S. S., Fass D. M., Yao H., Ellig C. L., Goodman R. H. and Stork P. J. (2000) Calcium and cAMP signals differentially regulate cAMP-responsive element-binding protein function via a Rap1-extracellular signal-regulated kinase pathway. J. Biol. Chem. 275, 34 433-34 441.
21. Grumolato L., Elkahloun A. G., Ghzili H. et al. (2003a) Microarray and suppression subtractive hybridization analyses of gene expression in pheochromocytoma cells reveal pleiotropic effects of pituitary adenylate cyclase-activating polypeptide on cell proliferation, survival, and adhesion. Endocrinology 144, 2368-2379.
22. Gnimolato L., Louiset E., Alexandre D., Ait-Ali D., Turquier V., Fournier A., Fasolo A., Vaudry H. and Anouar Y. (2003b) PACAP and NGF regulate common and distinct traits of the sympathoadrenal lineage: effects on electrical properties, gene markers and transcription factors in differentiating PC12 cells. Eur. J. Neurosci. 17, 71-82.
23. Gunning P. W., Landreth G. E., Bothwell M. A. and Shooter E. M. (1981a) Differential and synergistic actions of nerve growth factor and cyclic AMP in PC12 cells. J. Cell Biol. 89, 240-245.
24. Gunning P. W., Landreth G. E., Layer P., Ignatius M. and Shooter E. M. (1981b) Nerve growth factor-induced differentiation of PC12 cells: evaluation of changes in RNA and DNA metabolism. J. Neurosci. 1, 368-379.
25. Hamelink C., Lee H. W., Chen Y., Grimaldi M. and Eiden L. E. (2002) Coincident elevation of cAMP and calcium influx by PACAP-27 synergistically regulates vasoactive intestinal polypeptide gene transcription through a novel PKA-independent signaling pathway. J. Neurosci. 22, 5310-5320.
26. Han P. and Lucero M. T. (2005) Pituitary adenylate cyclase-activating polypeptide reduces A-type K+ currents and caspase activity in cultured adult mouse olfactory neurons. Neuroscience 134, 745-756.
27. Harada T., Morooka T., Ogawa S. and Nishida E. (2001) ERK induces p35, a neuron-specific activator of Cdk5, through induction of Egr1. Nat. Cell Biol. 3, 453-459.
28. Harmar A. J., Arimura A., Gozes I. et al. (1998) International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev. 50, 265-270.
29. Hartfield P. J., Bilney A. J. and Murray A. W. (1998) The role of c-Jun N-terminal kinase activation in ceramide-induced apoptosis in PC12 cells. Biochem. Soc. Trans. 26, S327.
30. Hashimoto H., Hagihara N., Koga K., Yamamoto K., Shintani N., Tomimoto S., Mori W., Koyama Y., Matsuda T. and Baba A. (2000) Synergistic induction of pituitary adenylate cyclase-activating polypeptide (PACAP) gene expression by nerve growth factor and PACAP in PC12 cells. J. Neurochem. 74, 501-507.
31. Hernandez A., Kimball B., Romanchuk G. and Mulholland M. W. (1995) Pituitary adenylate cyclase-activating peptide stimulates neurite growth in PC12 cells. Peptides 16, 927-932.
32. Heumann R., Kachel V. and Thoenen H. (1983) Relationship between NGF-mediated volume increase and 'priming effect' in fast- and slow-reacting clones of PC 12 pheochromocytoma cells. Role of cAMP. Exp. Cell Res. 145, 179-190.
33. Huang C. M., Shui H. A., Wu Y. T., Chu P. W., Lin K. G., Kao L. S. and Chen S. T. (2001) Proteomic analysis of proteins in PC12 cells before and after treatment with nerve growth factor: increased levels of a 43-kDa chromogranin B-derived fragment during neuronal differentiation. Mol. Brain Res. 92, 181-192.
34. Ishido M. and Masuo Y. (2004) Transcriptome of pituitary adenylate cyclase-activating polypeptide-differentiated PC12 cells. Regul. Pept. 123, 15-21.
35. Jacovina A. T., Zhong F., Khazanova E., Lev E., Deora A. B. and Hajjar K. A. (2001) Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation. J. Biol. Chem. 276, 49 350-49 358.
36. Jamen F., Bouschet T., Laden J. C., Bockaert J. and Brabet P. (2002) Up-regulation of the PACAP type-1 receptor (PAC1) promoter by neurotrophins in rat PC12 cells and mouse cerebellar granule cells via the Ras/mitogen-activated protein kinase cascade. J. Neurochem. 82, 1199-1207.
37. Kao S., Jaiswal R. K., Kolch W. and Landreth G. E. (2001) Identification of the mechanisms regulating the differential activation of the MAPK cascade by epidermal growth factor and nerve growth factor in PC12 cells. J. Biol. Chem. 276, 18 169-18 177.
38. Kim T., Tao-Cheng J. H., Eiden L. E. and Loh Y. P. (2001) Chromogranin A, an 'on/off' switch controlling dense-core secretory granule biogenesis. Cell 106, 499-509.
39. Kim U. H., Fink D., Kim H. S., Park D. J., Contreras M. L., Guroff G. and Rhee S. G. (1991) Nerve growth factor stimulates phosphorylation of phospholipase Cγ in PC12 cells. J. Biol. Chem. 266, 1359-1362.
40. Lange-Carter C. A. and Johnson G. L. (1994) Ras-dependent growth factor regulation of MEK kinase in PC12 cells. Science 265, 1458-1461.
41. Lazarovici P. and Fink D. (1999) Heterologous upregulation of nerve growth factor-TrkA receptors in PC12 cells by pituitary adenylate cyclase-activating polypeptide (PACAP). Mol. Cell Biol. Res. Commun. 2, 97-102.
42. Lazarovici P., Jiang H. and Fink D. (1998) The 38-amino-acid form of pituitary adenylate cyclase-activating polypeptide induces neurite outgrowth in PC12 cells that is dependent on protein kinase C and extracellular signal-regulated kinase but not on protein kinase A, nerve growth factor receptor tyrosine kinase, p21 (ras) G protein, and pp60 (c-src) cytoplasmic tyrosine kinase. Mol. Pharmacol. 54, 547-558.
43. Lebon A., Seyer D., Cosette P. et al. (2006) Identification of proteins regulated by PACAP in PC12 cells by 2D gel electrophoresis coupled to mass spectrometry. Ann. NY Acad. Sci. 1067, in press.
44. Lee K. H., Ryu C. J., Hong H. J., Kim J. and Lee E. H. (2005) cDNA microarray analysis of nerve growth factor-regulated gene expression profile in rat PC12 cells. Neurochem. Res. 30, 533-540.
45. Leppä S., Eriksson M., Saffrich R., Ansorge W. and Bohmann D. (2001) Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells. Mol. Cell Biol. 21, 4369-4378.
46. Lu N. and DiCicco-Bloom E. (1997) Pituitary adenylate cyclase-activating polypeptide is an autocrine inhibitor of mitosis in cultured cortical precursor cells. Proc. Natl Acad. Sci. USA 94, 3357-3362.
47. Mahapatra N. R., O'Connor D. T., Vaingankar S. M. et al. (2005) Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J. Clin. Invest. 115, 1942-1952.
48. Maillet M., Robert S. J., Cacquevel M., Gastineau M., Vivien D., Bertoglio J., Zugaza J. L., Fischmeister R. and Lezoualc'h F. (2003) Crosstalk between Rap1 and Rac regulates secretion of sAPPα Nat. Cell Biol. 5, 633-639.
49. Masiakowski P. and Shooter E. M. (1990) Changes in PC12 cell morphology induced by transfection with 42C cDNA, coding for a member of the S-100 protein family. J. Neurosci. Res. 27, 264-269.
50. McCulloch D. A., Lutz E. M., Johnson M. S., Robertson D. N., MacKenzie C. J., Holland P. J. and Mitchell R. (2001) ADP-ribosylation factor-dependent phospholipase D activation by VPAC receptors and a PAC(1) receptor splice variant. Mol. Pharmacol. 59, 1523-1532.
51. McTigue M., Cremins J. and Halegoua S. (1985) Nerve growth factor and other agents mediate phosphorylation and activation of tyrosine hydroxylase. A convergence of multiple kinase activities. J. Biol. Chem. 260, 9047-9056.
52. Minneman K. P., Lee D., Zhong H., Berts A., Abbott K. L. and Murphy T. J. (2000) Transcriptional responses to growth factor and G protein-coupled receptors in PC12 cells: comparison of α(1)-adrenergic receptor subtypes. J. Neurochem. 74, 2392-2400.
53. Miyata A., Arimura A., Dahl R. R., Minamino N., Uehara A., Jiang L., Culler M. D. and Coy D. H. (1989) Isolation of a novel 38-residue hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem. Biophys. Res. Commun. 164, 567-574.
54. Mochizuki N., Yamashita S., Kurokawa K., Ohba Y., Nagai T., Miyawaki A. and Matsuda M. (2001) Spatio-temporal images of growth-factor-induced activation of Ras and Rap1. Nature 411, 1065-1108.
55. Monnier D. and Loeffler J. P. (1998) Pituitary adenylate cyclase-activating polypeptide stimulates proenkephalin gene transcription through AP1- and CREB-dependent mechanisms. DNA Cell Biol 17, 151-159.
56. Moro O., Wakita K., Ohnuma M., Denda S., Lerner E. A. and Tajima M. (1999) Functional characterization of structural alterations in the sequence of the vasodilatory peptide maxadilan yields a pituitary adenylate cyclase-activating peptide type 1 receptor-specific antagonist. J. Biol. Chem. 274, 23103-23110.
57. Murphy L. O., Smith S., Chen R. H., Fingar D. C. and Blenis J. (2002) Molecular interpretation of ERK signal duration by immediate early gene products. Nat. Cell Biol. 4, 556-564.
58. Nicot A., Lelievre V., Tam J., Waschek J. A. and DiCicco-Bloom E. (2002) Pituitary adenylate cyclase-activating polypeptide and sonic hedgehog interact to control cerebellar granule precursor cell proliferation. J. Neurosci. 22, 9244-9254.
59. Nusser N., Gosmanova E., Zheng Y. and Tigyi G. (2002) Nerve growth factor signals through TrkA, phosphatidylinositol 3-kinase, and Rac1 to inactivate RhoA during the initiation of neuronal differentiation of PC12 cells. J. Biol. Chem. 277, 35 840-35 846.
60. Onoue S., Waki Y., Nagano Y., Satoh S. and Kashimoto K. (2001) The neuromodulatory effects of VTP/PACAP on PC-12 cells are associated with their N-terminal structures. Peptides 22, 867-872.
61. Onoue S., Endo K., Ohshima K., Yajima T. and Kashimoto K. (2002a) The neuropeptide PACAP attenuates β-amyloid (1-42)-induced toxicity in PC12 cells. Peptides 23, 1471-1478.
62. Onoue S., Endo K., Yajima T. and Kashimoto K. (2002b) Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide attenuate glutamate-induced nNOS activation and cytotoxicity. Regul. Pept. 107, 43-47.
63. Onoue S., Ohshima K., Endo K., Yajima T. and Kashimoto K. (2002c) PACAP protects neuronal PC12 cells from the cytotoxicity of human prion protein fragment 106-126. FEBS Lett. 522, 65-70.
64. Oshima M., Sithanandam G., Rapp U. R. and Guroff G. (1991) The phosphorylation and activation of B-raf in PC12 cells stimulated by nerve growth factor. J. Biol. Chem. 266, 23 753-23 760.
65. Osipenko O. N., Barrie A. P., Allen J. M. and Gurney A. M. (2000) Pituitary adenylyl cyclase-activating peptide activates multiple intracellular signaling pathways to regulate ion channels in PC12 cells. J. Biol. Chem. 275, 16 626-16 631.
66. Pang L., Sawada T., Decker S. J. and Saltiel A. R. (1995) Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol Chem. 270, 13 585-13 588.
67. Prentice H. M., Moore S. E., Dickson J. G., Doherty P. and Walsh F. S. (1987) Nerve growth factor-induced changes in neural cell adhesion molecule (N-CAM) in PC12 cells. EMBO J. 6, 1859-1863.
68. Rausch D. M., Iacangelo A. L. and Eiden L. E. (1988) Glucocorticoid-and nerve growth factor-induced changes in chromogranin A expression define two different neuronal phenotypes in PC12 cells. Mol. Endocrinol. 2, 921-927.
69. Ravni A., Eiden L. E., Vaudry H., Gonzalez B. J. and Vaudry D. (2006) Cycloheximide treatment to identify components of the transitional transcriptome in PACAP-induced PC12 cell differentiation. J. Neurochem., in press.
70. Reglodi D., Somogyvari-Vigh A., Vigh S., Kozicz T. and Arimura A. (2000) Delayed systemic administration of PACAP38 is neuroprotective in transient middle cerebral artery occlusion in the rat. Stroke 31, 1411-1417.
71. Robinson M. J., Stippec S. A., Goldsmith E., White M. A. and Cobb M. H. (1998) A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation. Curr. Biol. 8, 1141-1150.
72. Rudy B., Kirschenbaum B. and Greene L. A. (1982) Nerve growth factor-induced increase in saxitoxin binding to rat PC12 pheochromocytoma cells. J. Neurosci. 2, 1405-1411.
73. Said S. I., Dickman K., Dey R. D., Bandyopadhyay A., De Stefanis P., Raza S., Pakbaz H. and Berisha H. I. (1998) Glutamate toxicity in the lung and neuronal cells: prevention or attenuation by VIP and PACAP. Ann. NY Acad. Sci. 865, 226-237.
74. Sakai Y., Hashimoto H., Shintani N., Tomimoto S., Tanaka K., Ichibori A., Hirose M. and Baba A. (2001) Involvement of p38 MAP kinase pathway in the synergistic activation of PACAP mRNA expression by NGF and PACAP in PC12h cells. Biochem. Biophys. Res. Commun. 285, 656-661.
75. Sakai Y., Hashimoto H., Shintani N., Katoh H., Negishi M., Kawaguchi C., Kasai A. and Baba A. (2004) PACAP activates Rac1 and synergizes with NGF to activate ERK1/2, thereby inducing neurite outgrowth in PC12 cells. Mol. Brain Res. 123, 18-26.
76. Shimomura A., Okamoto Y., Hirata Y., Kobayashi M., Kawakami K., Kiuchi K., Wakabayashi T. and Hagiwara M. (1998) Dominant negative ATF1 blocks cyclic AMP-induced neurite outgrowth in PC12D cells. J. Neurochem. 70, 1029-1034.
77. Sofroniew M. V., Howe C. L. and Mobley W. C. (2001) Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 24, 1217-1281.
78. Suk K., Park J. H. and Lee W. H. (2004) Neuropeptide PACAP inhibits hypoxic activation of brain microglia: a protective mechanism against microglial neurotoxicity in ischemia. Brain Res. 1026, 151-156.
79. Tanaka J., Koshimura K., Murakami Y., Sohmiya M., Yanaihara N. and Kato Y. (1997) Neuronal protection from apoptosis by pituitary adenylate cyclase-activating polypeptide. Regul. Pept. 72, 1-8.
80. Töröcsik B., Angelastro J. M. and Greene L. A. (2002) The basic region and leucine zipper transcription factor MafK is a new nerve growth factor-responsive immediate early gene that regulates neurite outgrowth. J. Neurosci. 22, 8971-8980.
81. Tsukada Y., Chiba K., Yamazaki M. and Mohri T. (1994) Inhibition of the nerve growth factor-induced neurite outgrowth by specific tyrosine kinase and phospholipase inhibitors. Biol. Pharm. Bull. 17, 370-375.
82. Uchida D., Arimura A., Somogyvari-Vigh A., Shioda S. and Banks W. A. (1996) Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide. Brain Res. 736, 280-286.
83. Vanhoutte P., Nissen J. L., Brugg B., Gaspera B. D., Besson M. J., Hipskind R. A. and Caboche J. (2001) Opposing roles of Elk-1 and its brainspecific isoform, short Elk-1, in nerve growth factor-induced PC12 differentiation. J. Biol. Chem. 276, 5189-5196.
84. Vaudry D., Gonzalez B. J., Basille M., Anouar Y., Fournier A. and Vaudry H. (1998) Pituitary adenylate cyclase-activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase A pathway. Neuroscience 84, 801-812.
85. Vaudry D., Gonzalez B. J., Basille M., Pamantung T. F., Fontaine M., Fournier A. and Vaudry H. (2000a) The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32. Proc. Natl Acad. Sci. USA 97, 13 390-13 395.
86. Vaudry D., Gonzalez B. J., Basille M., Yon L., Fournier A. and Vaudry H. (2000b) Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol. Rev. 52, 269-324.
87. Vaudry D., Hsu C. M. and Eiden L. E. (2001) PACAP induces differentiation of rat pheochromocytoma PC12 cells through the cAMP/MAP kinase pathway. 5th International Symposium on VIP, PACAP, Secretin, Glucagon and Related Peptides, Santa Barbara, CA, USA, November 4-8. Regul. Pept. 102, 67.
88. Vaudry D., Chen Y., Hsu C. M. and Eiden L. E. (2002a) PC12 cells as a model to study the neurotrophic activities of PACAP. Ann. NY Acad. Sci. 971, 491-496.
89. Vaudry D., Chen Y., Ravni A., Hamelink C., Elkahloun A. G. and Eiden L. E. (2002b) Analysis of the PC12 cell transcriptome after differentiation with pituitary adenylate cyclase-activating polypeptide (PACAP). J. Neurochem. 83, 1272-1284.
90. Vaudry D., Stork P. J., Lazarovici P. and Eiden L. E. (2002c) Signaling pathways for PC12 cell differentiation: making the right connections. Science 296, 1648-1649.
91. Vaudry D., Falluel-Morel A., Basille M., Pamantung T. F., Fontaine M., Fournier A., Vaudry H. and Gonzalez B. J. (2003) Pituitary adenylate cyclase-activating polypeptide prevents C2-ceramide-induced apoptosis of cerebellar granule cells. J. Neurosci. Res. 72, 303-316.
92. Vaudry D., Ravni A., Wurtz O., Bénard M., Botia B., Jolivel V., Fournier A., Gonzalez B. J. and Vaudry H. (2006) Effects of PACAP in the local regulation of endocrine glands, in Handbook of Biologically Active Peptides (Kastin A. J. ed.), pp. 867-874. Academic Press, London.
93. Volonte C. and Greene L. A. (1990) Induction of ornithine decarboxylase by nerve growth factor in PC12 cells: dissection by purine analogues. J. Biol. Chem. 265, 11 050-11 055.
94. Vossler M. R., Yao H., York R. D., Pan M. G., Rim C. S. and Stork P. J. (1997) cAMP activates MAP kinase and Elk-1 through a B-Raf-and Rap1-dependent pathway. Cell 89, 73-82.
95. Wang G., Qi C., Fan G. H., Zhou H. Y. and Chen S. D. (2005) PACAP protects neuronal differentiated PC12 cells against the neurotoxicity induced by a mitochondrial complex I inhibitor, rotenone. FEBS Lett. 579, 4005-4011.
96. Waschek J. A., Casillas R. A., Nguyen T. B., DiCicco-Bloom E. M., Carpenter E. M. and Rodriguez W. I. (1998) Neural tube expression of pituitary adenylate cyclase-activating peptide (PACAP) and receptor: potential role in patterning and neurogenesis. Proc. Natl Acad. Sci. USA 95, 9602-9607.
97. Waskiewicz A. J., Flynn A., Proud C. G. and Cooper J. A. (1997) Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16, 1909-1920.
98. Wooten M. W., Seibenhener M. L., Neidigh K. B. and Vandenplas M. L. (2000) Mapping of atypical protein kinase C within the nerve growth factor signaling cascade: relationship to differentiation and survival of PC12 cells. Mol. Cell Biol. 20, 4494-4504.
99. Wu C., Lai C. F. and Mobley W. C. (2001) Nerve growth factor activates persistent Rap1 signaling in endosomes. J. Neurosci. 21, 5406-5416.
100. Xing J., Kornhauser J. M., Xia Z., Thiele E. A. and Greenberg M. E. (1998) Nerve growth factor activates extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways to stimulate CREB serine 133 phosphorylation. Mol. Cell Biol. 18, 1946-1955.
101. York R. D., Yao H., Dillon T., Ellig C. L., Eckert S. P., McCleskey E. W. and Stork P. J. (1998) Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 9, 622-626.
102. Yukimasa N., Isobe K., Nagai H., Takuwa Y. and Nakai T. (1999) Successive occupancy by immediate early transcriptional factors of the tyrosine hydroxylase gene TRE and CRE sites in PACAP-stimulated PC12 pheochromocytoma cells. Neuropeptides 33, 475-482.